The Vanguard Group 13D and 13G filings for Avalo Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-30 1:25 pm Purchase | 2025-12-31 | 13G | Avalo Therapeutics, Inc. AVTX | The Vanguard Group | 804,084 4.430% | 111,447 (+16.09%) | Filing |
| 2025-10-30 2:04 pm Purchase | 2025-09-30 | 13G | Avalo Therapeutics, Inc. AVTX | The Vanguard Group | 692,637 5.260% | 692,637 (New Position) | Filing |